Hypersplenism Completed Phase 1 / 2 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0001562 (Hypersplenism)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00605657Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS)Treatment